MediSense preparing for Precision QID glucose monitor launch in U.S..
This article was originally published in The Gray Sheet
Executive Summary
MEDISENSE PRECISION QID THIRD GENERATION GLUCOSE MONITORING SYSTEM will begin U.S. shipments "at or around the end of this quarter," MediSense Chairman and CEO Robert Coleman, PhD, said at a May 16 session of the Alex. Brown & Sons health care seminar in Baltimore. Both the home glucose monitoring device and attendant disposable strips were cleared by FDA on March 23.